Funding Information No funding information provided.
Microbial alginate production, modification and its applications
Article first published online: 19 AUG 2013
© 2013 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Thematic Issue on Biomaterials
Volume 6, Issue 6, pages 637–650, November 2013
How to Cite
Hay, I. D., Rehman, Z. U., Moradali, M. F., Wang, Y. and Rehm, B. H. A. (2013), Microbial alginate production, modification and its applications. Microbial Biotechnology, 6: 637–650. doi: 10.1111/1751-7915.12076
- Issue published online: 11 OCT 2013
- Article first published online: 19 AUG 2013
- Manuscript Accepted: 6 JUL 2013
- Manuscript Revised: 25 JUN 2013
- Manuscript Received: 9 APR 2013
- Massey University Research Fund
- Massey University Doctoral scholarship
- Higher Education Commission of Pakistan
- Top of page
- Microbial biosynthesis of alginate
- Applications of bacterial alginates
Alginate is an important polysaccharide used widely in the food, textile, printing and pharmaceutical industries for its viscosifying, and gelling properties. All commercially produced alginates are isolated from farmed brown seaweeds. These algal alginates suffer from heterogeneity in composition and material properties. Here, we will discuss alginates produced by bacteria; the molecular mechanisms involved in their biosynthesis; and the potential to utilize these bacterially produced or modified alginates for high-value applications where defined material properties are required.
- Top of page
- Microbial biosynthesis of alginate
- Applications of bacterial alginates
Alginates are a polysaccharides composed of variable ratios of β-D-mannuronate (M) and its C-5 epimer α-L-guluronate (G) linked by 1–4 glycosidic bonds (Fig. 1). Alginates were first isolated from brown seaweeds in the 1880s, and its commercial production begun in the early 20th century. Alginate can be produced by various genera of brown seaweed and two genera of bacteria, Pseudomonas and Azotobacter. The ratio of M and G residues and thus the material properties vary depending on the source of the alginate. Its unique physical properties enable it to be used as a stabilizer, viscosifier and gelling agent in the food, beverage, paper, printing and pharmaceutical industries. Industrial production of alginate is estimated to be at least 30,000 metric tons annually with all of that coming from farmed brown seaweed, primarily from the genera Laminaria and Macrocystis. In these seaweeds, alginate plays a structural role and constitutes up to 40% of the dry matter of the plant; it is thought to play a role analogous to cellulose in terrestrial plants (Draget et al., 2005; Donati and Paoletti, 2009). Recently, the desirable material properties as well as its apparent biocompatibility (Klock et al., 1997) has led to it being used increasingly in the medical, pharmaceutical and biotechnology industries for applications such as wound dressings (Thomas, 2000); the encapsulation or controlled release of drugs, enzymes or cells; or as a matrices for tissue engineering (Andersen et al., 2012; Lee and Mooney, 2012).
Microbial biosynthesis of alginate
- Top of page
- Microbial biosynthesis of alginate
- Applications of bacterial alginates
Two genera of bacteria have been shown to secrete alginate, Pseudomonas and Azotobacter. Most of the research into the molecular mechanisms behind bacterial alginate biosynthesis has been conducted on the opportunistic human pathogen Pseudomonas aeruginosa or the soil dwelling Azotobacter vinelandii. Although these two genera utilize very similar molecular mechanisms to produce alginate, in nature, they secrete alginate for different purposes with different material properties: Some P. aeruginosa strains (known as mucoid strains) can secrete copious amounts of alginate to aid in the formation of thick highly structured biofilms (Nivens et al., 2001; Hay et al., 2009a), whereas Azotobacter produces a stiffer alginate (with typically a higher concentrations of G residues) which remains closely associated with the cell and allows the formation of desiccation resistant cysts (Sabra and Ping Zeng, 2009).
The genes involved in alginate biosynthesis are virtually identical between Pseudomonas and Azotobacter though their regulation is slightly different. All but one of the core genes involved in alginate biosynthesis are contained within a single 12-gene operon initially described by Chitnis and Ohman (1993): algD, alg8, alg44, algK, algE (algJ), algG, algX, algL, algI, algJ (algV), algF and algA (Pseudomonas gene names are shown with the corresponding Azotobacter gene names in parentheses). The genes are under the tight control of a promoter upstream of algD (Schurr et al., 1993; Shankar et al., 1995), although there is some evidence to suggest that alternative internal promoters exist within the operon (Lloret et al., 1996; Paletta and Ohman, 2012). The gene algC is not located within the operon and is also involved in rhamnolipid and lipopolysaccharide biosynthesis (Goldberg et al., 1993; Ye et al., 1994; Olvera et al., 1999). In addition to these 13 core genes involved in alginate biosynthesis, many more have been identified and are summarized in Table 1. The steps of alginate biosynthesis can be loosely divided into four steps: precursor synthesis, polymerization, periplasmic modification/transit and export.
|AlgA||Precursor synthesis. Phosphomannose isomerase/GDP-mannose pyrophosphorylase.||Cytosol||(Shinabarger et al., 1991b)|
|AlgC||Precursor synthesis. Phosphomannomutase. PDB: 1P5G||Cytosol||(Ye et al., 1994)|
|AlgD||Precursor synthesis. GDP-mannose dehydrogenase. PDB: 1 MV8||Cytosol||(Tatnell et al., 1994)|
|Alg8||Polymerization. Proposed glycosyltransferase/polymerase.||IM||(Remminghorst et al., 2009)|
|Alg44||Polymerization and post transcriptional regulation. c-di-GMP binding and response.||IM||(Remminghorst and Rehm, 2006a)|
|AlgK||Export/structural role. Lipoprotein, Stabilizes AlgE in OM. PDB: 3EB4||Associated with periplasmic side of OM||(Keiski et al., 2010)|
|AlgE||Export. OM porin. Named AlgJ in Azotobacter. PDB: 3RBH||OM||(Whitney et al., 2011)|
|AlgG||M-G epimerization. Mannuronan C-5-epimerase||Periplasm||(Franklin et al., 1994)|
|AlgL||Alginate lyase. Control MW, clear alginate from the periplasm.||Periplasm||(Jain and Ohman, 2005)|
|AlgI||O-Acetylation||IM||(Franklin and Ohman, 2002)|
|AlgJ||O-Acetylation. Named AlgV in Azotobacter||IM||(Franklin and Ohman, 2002)|
|AlgF||O-Acetylation||Periplasm||(Franklin and Ohman, 2002)|
|AlgX||O-Acetylation. Structural role. Sequesters MucD. Structural role. PDB: 4KNC||Periplasm||(Gutsche et al., 2006; Riley et al., 2013)|
|AlgE1-E7||Azotobacter extracellular Mannuronan C-5-epimerases. PDB: 2PYG (AlgE4)||Extracellular||(Ertesvåg et al., 2009)|
|PA1167||Alginate lyase (polyguluronate lyase). PBD: 1VAV||Unknown||(Yamasaki et al., 2004)|
|AlgU (AlgT, σ22)||Alternative σ factor homologous to E. coli σE global stress response factor. Positive regulator||Cytosol||(Xie et al., 1996)|
|MucA||Anti σ factor. Negative regulator||IM||(Xie et al., 1996)|
|MucB||Stabilizes MucA. Negative regulator||Periplasm||(Cezairliyan and Sauer, 2009)|
|MucC||Unclear regulatory role||Periplasm/IM||(Boucher et al., 1997a)|
|MucD||Homologous to E. coli serine protease DegP. Negative regulator. Associated with Alginate complex. Negative regulator||Periplasm||(Wood and Ohman, 2006; Hay et al., 2012)|
|AlgW||Homologous to E. coli serine protease DegS. Cleaves MucA. Positive regulator||IM||(Cezairliyan and Sauer, 2009)|
|MucP||Homologous to E. coli RseP protease. Positive regulator, cleaves MucA||IM||(Qiu et al., 2007)|
|Prc||Protease. Positive regulator, cleaves MucA||Periplasm||(Wood et al., 2006)|
|MucE||Positive regulator, activates AlgW||OM/Periplasm||(Qiu et al., 2007)|
|ClpX/ClpP/ClpP2||Cytoplasmic proteases. Positive regulators, cleave MucA||Cytoplasm||(Qiu et al., 2008)|
|AlgR||Two-component regulator (Cognate sensor is AlgZ/FimS). Positive regulator, binds to 3 regions in the algD promoter||Cytoplasm||(Ma et al., 1998)|
|AlgB||NtrC-Family two-component regulator (Cognate sensor is KinB). Positive regulator, binds to one region in the algD promoter||Cytoplasm||(Ma et al., 1998)|
|AmrZ||Arc-like DNA-binding protein. Positive regulator, binds to one region in the algD promoter (originally named AlgZ). PDB: 3QOQ||Cytoplasm||(Baynham and Wozniak, 1996; Baynham et al., 2006)|
|AlgQ (AlgR2)||Positive regulator of nucleoside diphosphokinase, necessary for the formation of GDP-mannose||Cytoplasm||(Kim et al., 1998)|
|AlgP (AlgR3)||Histone-like protein required for normal alginate expression, but does not appear to bind algD promoter||Cytoplasm||(Kato et al., 1990)|
Alginate precursor synthesis
The formation of the activated precursor guanosine diphosphate (GDP)-mannuronic acid is a well-characterized process and is summarized in Fig. 2. It involves a series of cytosolic enzymatic steps feeding in to the membrane bound alginate polymerization machinery. Synthesis starts with the entry of six carbon substrates into the Entner–Doudoroff pathway, resulting in pyruvate, which is channelled towards the tricarboxylic acid cycle. Subsequently, oxaloacetate is converted to fructose-6-phosphate via gluconeogenesis (Lynn and Sokatch, 1984; Narbad et al., 1988). Three well-characterized enzymes, AlgA, AlgC and AlgD, catalyse the four next biosynthesis steps to convert fructose-6-phosphate to GDP-mannuronic acid and these enzymes have been. First, the conversion of fructose-6-phosphate to mannose-6-phosphate is catalysed by the phosphomannose isomerase activity of the bifunctional protein AlgA (May et al., 1994). Then, AlgC (phosphomannomutase) converts mannose-6-phosphate to mannose-1-phosphate (Zielinski et al., 1991) followed by the conversion to GDP-mannose which is catalysed by the GDP-mannose pyrophorylase activity of AlgA via the hydrolysis of GTP (Shinabarger et al., 1991a). Interestingly, this AlgA catalysed step favours the reverse reaction, but the pull of the subsequent AlgD catalysed step shifts the reaction towards GDP-mannose production. The final step is catalysed by AlgD (GDP-mannose dehydrogenase) and is irreversible resulting in GDP-mannuronic acid, which is substrate for the alginate polymerization machinery. The AlgD catalysed oxidation step is thought to be a key rate-limiting reaction in the alginate synthesis pathway (Roychoudhury et al., 1989; Tatnell et al., 1994; Tavares et al., 1999).
Polymerization and translocation are relatively poorly understood processes in alginate biosynthesis. Disruption mutagenesis shows that at least two proteins are required for polymerization: the inner membrane (IM) proteins Alg8 and Alg44 (Remminghorst and Rehm, 2006a; 2006b). Disruption of the alginate biosynthesis genes generally either results in one of three phenotypes: no loss of alginate production (AlgI, AlgJ and AlgF) (Franklin and Ohman, 2002); loss of alginate production but release alginate fragments due to the activity of a periplasmic alginate lyase (AlgX, AlgG, AlgK and AlgE) (Jain and Ohman, 1998; Jain et al., 2003; Gutsche et al., 2006; Hay et al., 2010); or complete loss of alginate production and no alginate fragments, as is the case for Alg8 and Alg44 (Remminghorst and Rehm, 2006a; 2006b; Oglesby et al., 2008).
Bioinformatic analysis suggests that Alg8 is the best candidate for a polymerase. It is predicted to be a glycosyltransferase (family-2 GT), which catalyses the transfer of a sugar molecule from an activated donor to an acceptor molecule (e.g. a growing carbohydrate chain). In accordance with functionally similar transmembrane glycosyltransferases such as AcsAB (cellulose synthase) and Ch1 (chitin synthase), Alg8 showed a predicted structure with several transmembrane domains flanking a long cytoplasmic loop accommodating conserved motifs and catalytic residues. Site-directed mutagenesis of these predicted catalytic residues resulted in loss of alginate biosynthesis. Further experimental support for the direct involvement of Alg8 in alginate polymerization is the observation that overexpression of Alg8 led to overproduction of alginate causing a supermucoid phenotype (Hay et al., 2009a). This overproduction would seem to suggest that the polymerization reaction catalysed by Alg8 is a bottleneck in the biosynthesis pathway. Interestingly, in-vitro polymerization experiments showed that the entire cell envelope (IM and outer membrane plus associated proteins) was required for polymerization, suggesting that Alg8 requires other proteins for function (Remminghorst and Rehm, 2006b; Oglesby et al., 2008; Remminghorst et al., 2009).
The specific role Alg44 plays in polymerization and the mechanisms involved remain unclear, but Alg44 is thought to play an indirect role. Similar to alg8, deletion of alg44 gene resulted in no alginate polymerization, while its overexpression led to overproduction of alginate. Alg44 is predicted as a multidomain protein which consists of a cytoplasmic PilZ domain, a transmembrane region and a periplasmic domain which shows homology to the membrane fusion protein MexA, a membrane-bridging protein involved in the multidrug efflux system of P. aeruginosa (Remminghorst and Rehm, 2006a; Oglesby et al., 2008). The periplasmic membrane fusion protein domain suggests that Alg44 may play a structural role in bridging the membrane bound polymerase to the periplasmic and outer membrane components facilitating the transit, modification and secretion of alginate. The cytosolic PilZ domain of Alg44 has been shown to bind the bacterial secondary messenger bis-(3′–5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) and is essential for alginate biosynthesis (Merighi et al., 2007). Currently, it is unclear how the binding of c-di-GMP by Alg44 is conveyed to the polymerase (Alg8). Similar c-di-GMP-dependent carbohydrate polymerization processes have been observed in various other systems, and these can give us clues as to how this mechanism function here (Weinhouse et al., 1997; Franklin et al., 2011; Whitney et al., 2012; Steiner et al., 2013). In one recent study, it was shown that binding of c-di-GMP to the BcsA subunit of the cellulose synthase causes local conformational changes allowing UDP-glucose to access the catalytic site (Morgan et al., 2013).
Periplasmic translocation and modification
After polymerization, the nascent alginate chain (poly-M) is translocated across the periplasm by a putative multiprotein scaffold consisting of at least the periplasmic proteins AlgX, AlgG and AlgK (Jain and Ohman, 1998; Jain et al., 2003; Robles-Price et al., 2004). These proteins are thought to guide the alginate chain through the periplasm while protecting it from degradation by the periplasmic alginate lyase, AlgL. Intriguingly, it has been proposed AlgL itself also contributes to the formation of a stable periplasmic scaffold (Jain and Ohman, 2005). When components of the periplasmic scaffold are missing, alginate chain leaks into the periplasm where it is degraded by AlgL, releasing free uronic acid oligomers.
Initially, it seems somewhat counterintuitive to find an alginate degrading protein, AlgL, encoded within the alginate biosynthesis operon. Disruption of the algL gene in mucoid strains or mutation of the catalytic residues has proved to be difficult, often resulting in non-viability, or loss of mucoidity because of secondary mutations turning off alginate production. This suggests that both AlgL and its lyase activity are required for viability in mucoid strains, presumably serving a maintenance role by degrading misguided alginate trapped in the periplasm. AlgL may also actively control the length of the polymer as well as contribute to periplasmic translocation (Albrecht and Schiller, 2005; Bakkevig et al., 2005; Jain and Ohman, 2005). Recently, the details of the reaction catalysed by AlgL from P. aeruginosa were characterized. AlgL specifically cleaves the alginate chain via beta elimination, producing mannuronic acids with unsaturated non-reducing ends; the initial steps of this reaction are similar to epimerization. It was found to be a highly processive enzyme that operates preferentially on non-acetylated poly-mannuronan, though it was found to lack strict stereospecificity; it could cleave MM, MG and GG bonds yielding dimeric and trimeric products (Farrell and Tipton, 2012).
Although several studies have indicated that AlgX is essential for alginate production, until recently its exact role remained unclear. Robles-Price and colleagues (2004) proposed that AlgX forms part of the periplasmic scaffold facilitating alginate translocation and secretion. Studies by Gutsche and colleagues (2006) suggested that AlgX was also required for efficient polymerization. The high sequence identity between AlgX and AlgJ, a protein involved in the O-acetylation of alginate, may represent a shared domain for alginate binding. Recently, the structure of AlgX was solved, and it was shown to have two domains: an N terminal SGNH hydrolase domain involved in the acetylation of alginate and a C-terminal carbohydrate-binding module which is thought to aid in alginate binding and orientation (Riley et al., 2013).
AlgK, another protein essential for successful translocation of alginate through the periplasm, has an unclear function. AlgK has multiple tetratricopeptide-like (TPR-like) repeats, a feature characteristic of proteins involved in the assembly of multiprotein complexes. This suggests that AlgK may play an important role in the assembly of functional alginate biosynthesis machinery. Keiski and colleagues (2010) recently showed that AlgK is a lipoprotein associated with the outer membrane; moreover, it was shown that AlgK is required for localization of the alginate of the porin AlgE to the outer membrane.
While the nascent alginate chain is transported across the periplasmic space, it can be modified by O-acetylation and epimerization. Although the order of modification remains unknown, it is conceivable that O-acetylation precedes epimerization, as O-acetylation blocks subsequent epimerization or cleavage (Fig. 3). Although neither O-acetylation nor epimerization are essential for alginate production, they can significantly alter the material properties of the resulting alginate (Donati and Paoletti, 2009). The O-acetylation of alginate is unique to bacterial alginates and significantly increased the water holding capacity of alginate; it is required for efficient biofilm development by Pseudomonads as well as protecting the organism from immune responses (Nivens et al., 2001; Pier et al., 2001).
During its transit through the periplasm, the nascent alginate is O-acetylated by the combined activities of AlgI, AlgJ and AlgF; however, these proteins are not essential for alginate production. AlgX has also recently been implicated in acetylation of alginate; the Ser-His-Asp catalytic triad found in the SGNH-like hydrolase domain was shown to be essential for acetylation (Riley et al., 2013). These proteins add O-acetyl ester linkages at the C2 or C3 position of M residues (Fig. 3) (Franklin and Ohman, 2002; Franklin et al., 2004). The source of the acetyl group is currently unknown; however, acetyl-coenzyme A is the likely candidate. The acetyl group is thought to be transported to the periplasm by AlgI, a cytoplasmic membrane protein with limited homologies to a Bacillus subtilis protein Ipa-4r (DltB), which transports an activated precursor during lipoteichoic acid biosynthesis (Franklin and Ohman, 1996). The second enzyme required for O-acetylation, AlgJ, is a periplasmic protein associated with the cytoplasmic membrane which shows high homology to AlgX; both proteins have sugar-binding-hydrolysing domains likely to be involved in substrate binding (Robles-Price et al., 2004). Interestingly, algI and algJ are thought to be acquired by lateral gene transfer (Franklin et al., 2004). AlgF is unique in that it does not have sequence homology to other proteins involved in O-acetylation. Because O-acetylation can restrict epimerization and cleavage, being able to control the level of O-acetylation would allow some level of control over the extent of epimerization and molecular weight.
Epimerization of M residues to G residues leads to changes in material properties. Generally, the presence of G residues in alginates allows for the formation of gels in the presence of divalent cations such as Ca2+. The G residues must be found as consecutive stretches (designated ‘G-blocks’) to bind Ca2+ (Fig. 3). The overall amount and length of these G blocks affect several properties of the gels, including stiffness, swelling and porosity (Donati and Paoletti, 2009). G-blocks also allow for interchain ion binding in an ‘egg-box'-like structure: the divalent cation interacts with two neighbouring G residues as well as with two G residues in a second chain generating interchain linkages. This is essential for the formation of hydrogels, with higher concentration of G blocks leading to stiffer gels. It is thought that MM or MG blocks are generally incapable of binding divalent cations in this way and are thought to act as elastic ‘hinges’ between the cross linked chains, though Donati and co-workers (2005) have also demonstrated the ability of MG blocks to bind Ca2+ and to form gels in a similar manner.
AlgG is responsible for the periplasmic epimerization of M to G residues. AlgG is a bifunctional protein which specifically catalyses the epimerization of M residues to G via protonation-deprotonation of C5 on the M residue in the alginate; it also forms an essential part of the periplasmic scaffold which protects the nascent alginate chain from AlgL-mediated degradation. Epimerization is not essential for the production of high molecular weight (HMW) alginates; mutations disabling the catalytic residues of AlgG do not affect alginate yield (Gimmestad et al., 2003; Jain et al., 2003).
The catalytic residues of AlgG reside in a shallow groove situated in a right-handed beta-helix fold, a common motif of carbohydrate-binding and sugar-hydrolysing proteins (Douthit et al., 2005). The kinetics of this enzyme have been thoroughly examined, demonstrating that AlgG has higher affinity to larger substrates up to 20 residues (100 Å long) suggesting that several AlgG proteins may bind alginate simultaneously (Jerga et al., 2006b). While an apparent equilibrium of 75% G content is reached when AlgG is incubated with poly-M substrate in vitro, the G content of alginate produced by P. aeruginosa is significantly lower (typically less than 40%), suggesting that strict regulation and/or competition between modification pathways is occurring in vivo (Schurks et al., 2002; Jerga et al., 2006a).
It should be noted that in addition to periplasmic AlgG, A. vinelandii also possess at least seven extracellular alginate epimerases, AlgE1-E7 with differing specificities and non-random epimerization patterns (Ertesvåg et al., 2009).
The outer membrane beta barrel porin, AlgE, is responsible for the secretion of mature alginate (Hay et al., 2010). This protein is immunogenic and displays anion selectivity upon spontaneous incorporation into planar lipid bilayers (Rehm et al., 1994a; 1994b). Recently, the crystal structure of AlgE has been determined (Whitney et al., 2011) and functional residues of the protein thoroughly probed (Rehman and Rehm, 2013). Despite the lack of sequence similarity, AlgE was found to be structurally similar to OprD, a substrate-specific nutrient uptake channel. The AlgE pore is lined with highly conserved, charged amino acid residues, in-part formed by the extracellular loops L3 and L7 folding into the lumen of the pore, which have been suggested to confer selectivity towards alginate and/or facilitate its efficient secretion across the outer membrane. AlgE has an unusually long and flexible periplasmic loop (L8) which appears to act as a ‘stopper’ in the deduced structure. It is thought that this region may interact with other subunits of the alginate biosynthesis machinery such as the TPR domains of AlgK and/or the membrane fusion domains of Alg44. It has been proposed that AlgK and AlgE interact, and this pair shares homology to enzymes involved in cellulose, Pel and poly-β-1,6-N-acetyl-D-glucosamine biosynthesis (Keiski et al., 2010; Rehm, 2010).
Multiprotein alginate polymerization/secretion complex
As mentioned above, it has long been suggested that the members of the alginate biosynthesis machinery form a multiprotein complex spanning from the IM, through the periplasmic space and into the outer membrane. Several studies have elucidated the specific protein–protein interactions involved in this complex (Gutsche et al., 2006; Keiski et al., 2010; Hay et al., 2012; Rehman and Rehm, 2013; Rehman et al., 2013). Recently, Rehman and colleagues (2013) have undertaken a series of pull-down, cross-linking and mutual-stability experiments in an effort to map the specific protein–protein interactions in the multiprotein complex. This has led to a model for the alginate polymerization/secretion complex as depicted in Fig. 4 (with experimentally deduced interactions indicated by triangles). Intriguingly, a key regulatory protein, MucD, appears to interact with the complex through AlgX. It is unclear what the function of this interaction is, but it has been suggested that MucD may be sequestered by an intact complex and becomes free to exert its regulatory role if the complex becomes instable (Gutsche et al., 2006; Hay et al., 2012).
The regulation of alginate biosynthesis is complex and involves transcriptional and post-translational levels of regulation, as well as several hypermutable regions of the genome in which mutant alleles lead to overproduction of alginate. Globally acting regulators as well as several alginate-specific regulators govern alginate biosynthesis. Transcriptional regulation of alginate biosynthesis in P. aeruginosa can be loosely divided into two different types: environmental stimuli-based regulation and a ‘genotypic switch'-based form of regulation (Rehm and Valla, 1997).
Most of the genes involved in the genotypic switch are located within a single self-regulated operon (algU, mucA, mucB, mucC and mucD). This region is somewhat homologous to the well-characterized σE region in Escherichia coli, containing the genes rpoE (encoding the σE), rseA, rseB, rseC. AlgU is a key alternate σ22 factor, which is at the apex of a hierarchy of regulators involved in alginate biosynthesis and is ultimately required for transcription starting from the AlgD promoter (Chitnis and Ohman, 1993; Deretic et al., 1994; Firoved and Deretic, 2003; Ramsey and Wozniak, 2005). AlgU is sequestered at the IM (and thus unable to bind RNA polymerase and initiate transcription) by the membrane anchored anti-sigma factor MucA (Schurr et al., 1996; Xie et al., 1996; Mathee et al., 1997). The periplasmic protein MucB binds to the periplasmic side of MucA and plays a negative regulatory role in alginate biosynthesis by protecting MucA from proteolysis. Release of AlgU and subsequent transcription appears to be initiated by a regulated intramembrane proteolytic (RIP) cascade leading to the degradation of MucA (Wood et al., 2006; Cezairliyan and Sauer, 2009). Several steps of the RIP cascade have recently come to light: The periplasmic protease AlgW (E. coli DegS homologue) initially cleaves MucA in response to envelope stress. Particular misfolded proteins (in particular, the outer membrane protein MucE) can bind to the PDZ activating domain of AlgW and cause its activation (de-repression). After cleavage by AlgW, MucA becomes susceptible to cleavage on the cytosolic side by the intramembrane protease MucP (E. coli RseP/YaeL homologue) leading to the release of AlgU (Qiu et al., 2007, Damron and Yu, 2011) (Fig. 5). Three further cytosolic proteases, ClpX, ClpP1 and ClpP2, have recently been shown to be involved in the proteolysis of MucA (Qiu et al., 2008). MucD is a periplasmic protease that appears to be playing a role antagonistic to that of AlgW. Disruption of mucD gene leads to a mucoid phenotype signifying a negative regulatory role. It is thought that MucD is involved in the degradation of misfolded proteins that would otherwise activate AlgW or MucP (Wood and Ohman, 2006; 2009; Qiu et al., 2007; Damron and Yu, 2011). Although alginate production is the most apparent phenotype controlled by AlgU, it does not act exclusively on the alginate operon and has been shown to be involved in the transcriptional activation of genes with diverse functions, including genes involved in biosynthesis of other exopolysaccharides (Firoved et al., 2002; Firoved and Deretic, 2003; Ghafoor et al., 2011).
This operon has become known as the ‘switch’ locus because of the relatively high number of mutations found in this region in clinical mucoid isolates. The most common mutations occur in MucA and/or MucB, with up to 80% of mucoid P. aeruginosa clinical isolates containing mutations in the mucA gene. Most of these mutations result in a premature stop codon and a truncated MucA rendering the RIP cascade redundant (Martin et al., 1993a; 1993b; Boucher et al., 1997b; Ciofu et al., 2008; Pulcrano et al., 2012).
In addition to AlgU, several other proteins are required to initiate transcription of the alginate operon. This layer of regulation is known as ‘environmental stimuli'-based regulation. AlgR is a response regulator part of a two-component regulator that binds to three sites in the algD promoter; the cognate sensory component of this regulatory pair is AlgZ (FimS) and strangely is not required for transcription of the alginate operon. AlgB is also part of a two-component regulator and binds to one site on the algD promoter; again, it's activity is apparently independent of its cognate sensor kinase KinB (Ma et al., 1998). AmrZ (originally called AlgZ), an Arc-like DNA-binding protein, binds to one site on the algD promoter (Baynham and Wozniak, 1996; Baynham et al., 1999; 2006).
As mentioned above, the essential alginate biosynthesis protein Alg44 contains a c-di-GMP-binding/sensing PilZ domain in its C-terminus. This allows for an additional post-translational level of regulation (Merighi et al., 2007). C-di-GMP is an important bacterial secondary messenger that has been linked to the post-translational regulation of diverse processes such as motility, exopolysaccharide production and virulence (Amikam and Galperin, 2006). Recently, it has been demonstrated that one particular c-di-GMP-synthesizing protein, MucR, specifically influences the levels of alginate biosynthesis in P. aeruginosa presumably by generating a localized c-di-GMP pool in proximity to the alginate polymerization/secretion multiprotein complex (Hay et al., 2009b).
Applications of bacterial alginates
- Top of page
- Microbial biosynthesis of alginate
- Applications of bacterial alginates
All current commercial alginates are isolated from farmed brown seaweeds, with over 30,000 metric tons produced annually (Draget et al., 2005). Its material properties, versatility and biocompatibility has led to alginates use as a viscosity regulator and stabilizer in foods, cosmetics and high-value medical applications including wound dressings, drug delivery systems and more recently in tissue encapsulation for regenerative therapy (Tonnesen and Karlsen, 2002; Qin, 2008; Lim et al., 2010).
While bulk alginate extracted from seaweed for the food and cosmetic industries is sold at prices as low as $5 kg−1, pharmaceutical grade alginates with defined MW, M/G ratios and hence more defined material properties cost more than $100 g−1 (Pronova web catalogue prices as of April 2013). The high-value applications of alginate in biotechnology and biomedical sciences require a steady supply of alginates with defined homogeneity in composition and material properties. Although seaweed alginates are extensively used in biomedical applications as an immobilization material, it suffers from problems with mechanical stability, wide pore size distribution and osmotic swelling during physiological conditions. Furthermore, it is subject to heterogeneity in both ratio of G to M residues as well as molecular weight because of environmental and seasonal variation (Draget et al., 2005; Mørch et al., 2007; Andersen et al., 2012). This inability of algal alginate to fulfil specific demands created by biomedical industry can be overcome either by using bacterial alginate or using bacterial enzymes to modify algal alginates (Rehm, 2010).
Because of the pathogenic nature of P. aeruginosa, any commercial bacterial production of alginate is likely to come from A. vinelandii or non-pathogenic Pseudomonas species. The M/G residue composition of A. vinelandii alginate is similar to those produced by seaweeds. By exploiting regulatory proteins discussed above, it is possible to engineer A. vinelandii strains with increased levels of transcription from the algD operon and thus increased levels of alginate production. Indeed, when this was combined with disruption of the polyhydroxybutyrate pathway (thus allowing more carbon sources for alginate biosynthesis) up to 7 g l−1 of alginate was obtained (Pena et al., 2002; Galindo et al., 2007). Furthermore, disruption of the Na+-translocating NADH: ubiquinone oxidoreductase complex in A. vinelandii leads to an alginate overproducing phenotype, this alginate also had a higher degree of acetylation and a lower G/M ratio, though the exact mechanism remains unclear (Nunez et al., 2009; Gaytan et al., 2012).
Viscosity is also influenced by the molecular weight of alginate. HMW alginate (more viscous) can be produced by A. vinelandii when the dissolved oxygen is controlled and/or the algL gene is disrupted (Pena et al., 2000; Trujillo-Roldan et al., 2003; 2004; Diaz-Barrera et al., 2010). Recently, a study has linked the increased expression of alginate polymerase alg8/alg44 with the production of HMW alginate in A. vinelandii (Diaz-Barrera et al., 2012). Interestingly, a mutant of A. vinelandii, with increased expression of the algD operon and disruption of polyhydroxybutyrate biosynthesis, produced alginate with an extremely HMW (4000 kDa) (Pena et al., 2002).
As mentioned above, A. vinelandii secretes seven C-5 epimerases each introducing a specific ratio and pattern of G residues. For example, AlgE2 and AlgE6 introduces continuous stretches of G-residues forming G-blocks while AlgE4 actions results in the formation of MG blocks (Ertesvåg et al., 2009). Utilizing these enzymes allows a tighter control of the material properties of alginate. Indeed, A. vinelandii epimerases have been employed to modify alginate to exhibit material properties required for immobilization of living cells (Martinsen et al., 1989; Mørch et al., 2007). A mutant of P. fluorescence lacking the epimerase AlgG can be used to produce poly-M (Gimmestad et al., 2003). High M content alginates are of particular practical interest for some types of cell transplantations because of their particular material properties and biocompatibility (Klock et al., 1994; 1997); poly-Ms hydrolysis products are known to exert anti-inflammatory activity (Mirshafiey and Rehm, 2009).
As mentioned above, a key difference between algal and bacterial alginates is that the latter is O-acetylated. A higher degree of O-acetylation significantly increases viscosity and pseudoplastic rheology (Skjåk-Bræk et al., 1989; Donati and Paoletti, 2009). The level of O-acetylation can be controlled reasonably well using specific strains/mutants or altering the growth media and controlling cultivation conditions such as aeration, pH and temperature (Pena et al., 2006; Diaz-Barrera et al., 2010; Gaytan et al., 2012). In addition, live immobilized P. syringae cells have been successfully used to acetylate seaweed-derived alginates (Lee and Day, 1995).
Understanding and harnessing these mechanisms of alginate production and modification in bacteria could enable manufacture of tailor made bacterial alginates for high value medical and biotechnological applications.
- Top of page
- Microbial biosynthesis of alginate
- Applications of bacterial alginates
This work is supported by grants from Massey University Research Fund to B.H.A.R. M.F.M is funded by a Massey University Doctoral scholarship. Z.U.R is supported by a Doctoral scholarship and research grant from the Higher Education Commission of Pakistan.
- Top of page
- Microbial biosynthesis of alginate
- Applications of bacterial alginates
- 2005) Alginate lyase (AlgL) activity is required for alginate biosynthesis in Pseudomonas aeruginosa. J Bacteriol 187: 3869–3872. , and (
- 2006) PilZ domain is part of the bacterial c-di-GMP binding protein. Bioinformatics 22: 3–6. , and (
- 2012) Alginates as biomaterials in tissue engineering. In Carbohydrate Chemistry: Chemical and Biological Approaches. Vol. 37. Rauter, A.P. (ed.). Cambridge, UK: The Royal Society of Chemistry, pp. 227–258. , , , , and (
- 2005) Role of the Pseudomonas fluorescens alginate lyase (AlgL) in clearing the periplasm of alginates not exported to the extracellular environment. J Bacteriol 187: 8375–8384. , , , , , , et al. (
- 1996) Identification and characterization of AlgZ, an AlgT-dependent DNA-binding protein required for Pseudomonas aeruginosa algD transcription. Mol Microbiol 22: 97–108. , and (
- 1999) Pseudomonas aeruginosa AlgZ, a ribbon-helix-helix DNA-binding protein, is essential for alginate synthesis and algD transcriptional activation. Mol Microbiol 33: 1069–1080. , , , and (
- 2006) The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili. J Bacteriol 188: 132–140. , , , , and (
- 1997a) Pseudomonas aeruginosa in cystic fibrosis: role of mucC in the regulation of alginate production and stress sensitivity. Microbiology 143 (Pt 11): 3473–3480. , , , , and (
- 1997b) Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65: 3838–3846. , , , and (
- 2009) Control of Pseudomonas aeruginosa AlgW protease cleavage of MucA by peptide signals and MucB. Mol Microbiol 72: 368–379. , and (
- 1993) Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure. Mol Microbiol 8: 583–593. , and (
- 2008) Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154: 103–113. , , , , , and (
- 2011) Pseudomonas aeruginosa MucD regulates the alginate pathway through activation of MucA degradation via MucP proteolytic activity. J Bacteriol 193: 286–291. , and (
- 1994) Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J Bacteriol 176: 2773–2780. , , , and (
- 2010) Manipulating the molecular weight of alginate produced by Azotobacter vinelandii in continuous cultures. Bioresour Technol 101: 9405–9408. , , , and (
- 2012) Alginate production and alg8 gene expression by Azotobacter vinelandii in continuous cultures. J Ind Microbiol Biotechnol 39: 613–621. , , and (
- 2009) Material properties of alginates. In Alginates: Biology and Applications. Rehm, B.H.A. (ed.). Berlin, Heidelberg, Genmany: Springer Berlin Heidelberg, pp. 1–53. , and (
- 2005) New hypothesis on the role of alternating sequences in calcium-alginate gels. Biomacromolecules 6: 1031–1040. , , , , , and (
- 2005) Epimerase active domain of Pseudomonas aeruginosa AlgG, a protein that contains a right-handed beta-helix. J Bacteriol 187: 4573–4583. , , , and (
- 2005) Alginates from algae. Biopolymers Online. doi: 10.1002/3527600035.bpol6008. , , and (
- 2009) Enzymatic Alginate Modification. In Alginates: Biology and Applications. Rehm, B.H.A. (ed.). Berlin, Heidelberg, Genmany: Springer Berlin Heidelberg, pp. 95–115. , , and (
- 2012) Functional characterization of AlgL, an alginate lyase from Pseudomonas aeruginosa. Biochemistry 51: 10259–10266. , and (
- 2003) Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J Bacteriol 185: 1071–1081. , and (
- 2002) Global genomic analysis of AlgU (sigma(E))-dependent promoters (sigmulon) in Pseudomonas aeruginosa and implications for inflammatory processes in cystic fibrosis. J Bacteriol 184: 1057–1064. , , and (
- 1996) Identification of algI and algJ in the Pseudomonas aeruginosa alginate biosynthetic gene cluster which are required for alginate O acetylation. J Bacteriol 178: 2186–2195. , and (
- 2002) Mutant analysis and cellular localization of the AlgI, AlgJ, and AlgF proteins required for O acetylation of alginate in Pseudomonas aeruginosa. J Bacteriol 184: 3000–3007. , and (
- 1994) Pseudomonas aeruginosa AlgG is a polymer level alginate C5-mannuronan epimerase. J Bacteriol 176: 1821–1830. , , , , , and (
- 2004) Evidence that the algI/algJ gene cassette, required for O acetylation of Pseudomonas aeruginosa alginate, evolved by lateral gene transfer. J Bacteriol 186: 4759–4773. , , and (
- 2011) Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front Microbiol 2: 167. , , , and (
- 2007) Molecular and bioengineering strategies to improve alginate and polydydroxyalkanoate production by Azotobacter vinelandii. Microb Cell Fact 6: 7. , , , , and (
- 2012) Azotobacter vinelandii lacking the Na(+)-NQR activity: a potential source for producing alginates with improved properties and at high yield. World J Microbiol Biotechnol 28: 2731–2740. , , , , , and (
- 2011) Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl Environ Microbiol 77: 5238–5246. , , and (
- 2003) The Pseudomonas fluorescens AlgG protein, but not its mannuronan C-5-epimerase activity, is needed for alginate polymer formation. J Bacteriol 185: 3515–3523. , , , , , , et al. (
- 1993) Synthesis of lipopolysaccharide O side chains by Pseudomonas aeruginosa PAO1 requires the enzyme phosphomannomutase. J Bacteriol 175: 1605–1611. , , and (
- 2006) Biochemical analysis of alginate biosynthesis protein AlgX from Pseudomonas aeruginosa: purification of an AlgX-MucD (AlgY) protein complex. Biochimie 88: 245–251. , , and (
- 2009a) Impact of alginate overproduction on attachment and biofilm architecture of a supermucoid Pseudomonas aeruginosa strain. Appl Environ Microbiol 75: 6022–6025. , , , , and (
- 2009b) MucR, a novel membrane-associated regulator of alginate biosynthesis in Pseudomonas aeruginosa. Appl Environ Microbiol 75: 1110–1120. , , and (
- 2010) Membrane topology of outer membrane protein AlgE, which is required for alginate production in Pseudomonas aeruginosa. Appl Environ Microbiol 76: 1806–1812. , , and (
- 2012) Identification of a periplasmic AlgK-AlgX-MucD multiprotein complex in Pseudomonas aeruginosa involved in biosynthesis and regulation of alginate. Appl Microbiol Biotechnol 93: 215–227. , , , and (
- 1998) Deletion of algK in mucoid Pseudomonas aeruginosa blocks alginate polymer formation and results in uronic acid secretion. J Bacteriol 180: 634–641. , and (
- 2005) Role of an alginate lyase for alginate transport in mucoid Pseudomonas aeruginosa. Infect Immun 73: 6429–6436. , and (
- 2003) The dual roles of AlgG in C-5-epimerization and secretion of alginate polymers in Pseudomonas aeruginosa. Mol Microbiol 47: 1123–1133. , , , , and (
- 2006a) Pseudomonas aeruginosa C5-mannuronan epimerase: steady-state kinetics and characterization of the product. Biochemistry 45: 552–560. , , and (
- 2006b) Chemical mechanism and specificity of the C5-mannuronan epimerase reaction. Biochemistry 45: 9138–9144. , , and (
- 1990) AlgR3, a protein resembling eukaryotic histone H1, regulates alginate synthesis in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 87: 2887–2891. , , and (
- 2010) AlgK is a TPR-containing protein and the periplasmic component of a novel exopolysaccharide secretin. Structure 18: 265–273. , , , , , , et al. (
- 1998) Alginate, inorganic polyphosphate, GTP and ppGpp synthesis co-regulated in Pseudomonas aeruginosa: implications for stationary phase survival and synthesis of RNA/DNA precursors. Mol Microbiol 27: 717–725. , , , , , and (
- 1994) Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40: 638–643. , , , , , , et al. (
- 1997) Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18: 707–713. , , , , , , and (
- 1995) Bioacetylation of seaweed alginate. Appl Environ Microbiol 61: 650–655. , and (
- 2012) Alginate: properties and biomedical applications. Prog polym sci 37: 106–126. , and (
- 2010) Cell microencapsulation. Adv Exp Med Biol 670: 126–136. , , , and (
- 1996) Genetic analysis of the transcriptional arrangement of Azotobacter vinelandii alginate biosynthetic genes: identification of two independent promoters. Mol Microbiol 21: 449–457. , , , , , , and (
- 1984) Incorporation of isotope from specifically labeled glucose into alginates of Pseudomonas aeruginosa and Azotobacter vinelandii. J Bacteriol 158: 1161–1162. , and (
- 1998) Phosphorylation-independent activity of the response regulators AlgB and AlgR in promoting alginate biosynthesis in mucoid Pseudomonas aeruginosa. J Bacteriol 180: 956–968. , , , , , and (
- 1993a) Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol Microbiol 9: 497–506. , , , and (
- 1993b) Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A 90: 8377–8381. , , , , , and (
- 1989) Alginate as immobilization material: I. correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng 33: 79–89. , , and (
- 1997) Posttranslational control of the algT (algU)-encoded sigma22 for expression of the alginate regulon in Pseudomonas aeruginosa and localization of its antagonist proteins MucA and MucB (AlgN). J Bacteriol 179: 3711–3720. , , and (
- 1994) Identification of amino-acid-residues involved in the activity of phosphomannose isomerase-guanosine 5′-diphospho-D-mannose pyrophosphorylase – a bifunctional enzyme in the alginate biosynthetic-pathway of Pseudomonas aeruginosa. J Biol Chem 269: 4872–4877. , , , and (
- 2007) The second messenger bis-(3′-5′)-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol Microbiol 65: 876–895. , , , , and (
- 2009) Alginate and its comonomer mannuronic acid: medical relevance as drugs. In Alginates: Biology and Applications. Rehm, B.H.A. (ed.). Berlin Heidelberg, Genmany: Springer Berlin Heidelberg, pp. 229–260. , and (
- 2007) Molecular engineering as an approach to design new functional properties of alginate. Biomacromolecules 8: 2809–2814. , , , and (
- 2013) Crystallographic snapshot of cellulose synthesis and membrane translocation. Nature 493: 181–186. , , and (
- 1988) Radiolabelling patterns in alginate of Pseudomonas aeruginosa synthesized from specifically-labelled 14C-monosaccharide precursors. Microbios 54: 171–179. , , and (
- 2001) Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. J Bacteriol 183: 1047–1057. , , , and (
- 2009) The Na+-translocating NADH : ubiquinone oxidoreductase of Azotobacter vinelandii negatively regulates alginate synthesis. Microbiology 155: 249–256. , , , , , and (
- 2008) Membrane topology and roles of Pseudomonas aeruginosa Alg8 and Alg44 in alginate polymerization. Microbiology 154: 1605–1615. , , and (
- 1999) The Pseudomonas aeruginosa algC gene product participates in rhamnolipid biosynthesis. FEMS Microbiol Lett 179: 85–90. , , , and (
- 2012) Evidence for two promoters internal to the alginate biosynthesis operon in Pseudomonas aeruginosa. Curr Microbiol 65: 770–775. , and (
- 2000) Influence of dissolved oxygen tension and agitation speed on alginate production and its molecular weight in cultures of Azotobacter vinelandii. Enzyme Microb Technol 27: 390–398. , , and (
- 2002) Alginate production by Azotobacter vinelandii mutants altered in poly-beta-hydroxybutyrate and alginate biosynthesis. J Ind Microbiol Biotechnol 29: 209–213. , , , , , and (
- 2006) Manipulation of the acetylation degree of Azotobacter vinelandii alginate by supplementing the culture medium with 3-(N-morpholino)-propane-sulfonic acid. Lett Appl Microbiol 43: 200–204. , , and (
- 2001) Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun 69: 1895–1901. , , , , and (
- 2012) Different mutations in mucA gene of Pseudomonas aeruginosa mucoid strains in cystic fibrosis patients and their effect on algU gene expression. New Microbiol 35: 295–305. , , , , and (
- 2008) Alginate fibres: an overview of the production processes and applications in wound management. Polym Int 57: 171–180. (
- 2007) Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104: 8107–8112. , , , and (
- 2008) ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology 154: 2119–2130. , , , , and (
- 2005) Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol 56: 309–322. , and (
- 2010) Bacterial polymers: biosynthesis, modifications and applications. Nat Rev Microbiol 8: 578–592. (
- 1997) Bacterial alginates: biosynthesis and applications. Appl Microbiol Biotechnol 48: 281–288. , and (
- 1994a) Overexpression of algE in Escherichia coli: subcellular localization, purification, and ion channel properties. J Bacteriol 176: 5639–5647. , , , and (
- 1994b) Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa. Microb Pathog 16: 43–51. , , , and (
- 2013) Dual roles of Pseudomonas aeruginosa AlgE in secretion of the virulence factor Alginate and formation of the secretion complex. Appl Environ Microbiol 79: 2002–2011. , and (
- 2013) Insight into assembly of the alginate biosynthesis machinery in Pseudomonas aeruginosa. Appl Environ Microbiol 79: 3264–3272. , , , , and (
- 2006a) Alg44, a unique protein required for alginate biosynthesis in Pseudomonas aeruginosa. FEBS Lett 580: 3883–3888. , and (
- 2006b) In vitro alginate polymerization and the functional role of Alg8 in alginate production by Pseudomonas aeruginosa. Appl Environ Microbiol 72: 298–305. , and (
- 2009) Molecular characterization of Alg8, a putative glycosyltransferase, involved in alginate polymerisation. J Biotechnol 140: 176–183. , , and (
- 2013) Structural and functional characterization of Pseudomonas aeruginosa AlgX: role of AlgX in alginate acetylation. J Biol Chem [Epub ahead of print]. , , , , , , et al. (
- 2004) AlgX is a periplasmic protein required for alginate biosynthesis in Pseudomonas aeruginosa. J Bacteriol 186: 7369–7377. , , , , and (
- 1989) Purification and characterization of guanosine diphospho-D-mannose dehydrogenase – a key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosa. J Biol Chem 264: 9380–9385. , , , , , and (
- 2009) Microbial production of alginates: physiology and process aspects. In Alginates: Biology and Applications. Rehm, B.H.A. (ed.). Berlin Heidelberg, Genmany: Springer-Verlag, pp. 153–173. , and (
- 2002) Monomer composition and sequence of alginates from Pseudomonas aeruginosa. Int J Biol Macromol 30: 105–111. , , , and (
- 1993) The algD promoter: regulation of alginate production by Pseudomonas aeruginosa in cystic fibrosis. Cell Mol Biol Res 39: 371–376. , , , , , and (
- 1996) Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J Bacteriol 178: 4997–5004. , , , , and (
- 1995) Exopolysaccharide alginate synthesis in Pseudomonas aeruginosa: enzymology and regulation of gene expression. Adv Enzymol Relat Areas Mol Biol 70: 221–255. , , , and (
- 1991a) Purification and characterization of phosphomannose isomerase-guanosine diphospho-D-mannose pyrophosphorylase – a bifunctional enzyme in the alginate biosynthetic-pathway of Pseudomonas aeruginosa. J Biol Chem 266: 2080–2088. , , , , , and (
- 1991b) Purification and characterization of phosphomannose isomerase-guanosine diphospho-D-mannose pyrophosphorylase. A bifunctional enzyme in the alginate biosynthetic pathway of Pseudomonas aeruginosa. J Biol Chem 266: 2080–2088. , , , , , and (
- 1989) Effect of acetylation on some solution and gelling properties of alginates. Carbohydr Res 185: 131–138. , , and (
- 2013) Allosteric activation of exopolysaccharide synthesis through cyclic di-GMP-stimulated protein-protein interaction. EMBO J 32: 354–368. , , , and (
- 1994) GDP-mannose dehydrogenase is the key regulatory enzyme in alginate biosynthesis in Pseudomonas aeruginosa: evidence from metabolite studies. Microbiology 140 (Pt 7): 1745–1754. , , and (
- 1999) Pattern of changes in the activity of enzymes of GDP-D-mannuronic acid synthesis and in the level of transcription of algA, algC and algD genes accompanying the loss and emergence of mucoidy in Pseudomonas aeruginosa. Res Microbiol 150: 105–116. , , , and (
- 2000) Alginate dressings in surgery and wound management–Part 1. J Wound Care 9: 56–60. (
- 2002) Alginate in drug delivery systems. Drug Dev Ind Pharm 28: 621–630. , and (
- 2003) Alginate production by an Azotobacter vinelandii mutant unable to produce alginate lyase. Appl Microbiol Biotechnol 60: 733–737. , , , , and (
- 2004) The roles of oxygen and alginate-lyase in determining the molecular weight of alginate produced by Azotobacter vinelandii. Appl Microbiol Biotechnol 63: 742–747. , , , and (
- 1997) c-di-GMP-binding protein, a new factor regulating cellulose synthesis in Acetobacter xylinum. FEBS Lett 416: 207–211. , , , , , , and (
- 2011) Structural basis for alginate secretion across the bacterial outer membrane. Proc Natl Acad Sci U S A 108: 13083–13088. , , , , , , et al. (
- 2012) Structure of the cytoplasmic region of PelD, a degenerate diguanylate cyclase receptor that regulates exopolysaccharide production in Pseudomonas aeruginosa. J Biol Chem 287: 23582–23593. , , , , , and (
- 2006) Independent regulation of MucD, an HtrA-like protease in Pseudomonas aeruginosa, and the role of its proteolytic motif in alginate gene regulation. J Bacteriol 188: 3134–3137. , and (
- 2009) Use of cell wall stress to characterize sigma 22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa. Mol Microbiol 72: 183–201. , and (
- 2006) Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa: Roles of sigma (AlgT) and the AlgW and Prc proteases. Mol Microbiol 62: 412–426. , , and (
- 1996) Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA. J Bacteriol 178: 4990–4996. , , , , and (
- 2004) Structure and function of a hypothetical Pseudomonas aeruginosa protein PA1167 classified into family PL-7: a novel alginate lyase with a beta-sandwich fold. J Biol Chem 279: 31863–31872. , , , , , and (
- 1994) Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide. J Bacteriol 176: 4851–4857. , , and (
- 1991) Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase. J Biol Chem 266: 9754–9763. , , and (